Approval · Notice of Compliance 6729 · 2005
TRASYLOL: Notice of Compliance 6729
Issued May 13, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6729
- Date
- May 13, 2005
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Polypeptide proteinase inhibitor / hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRASYLOL | Not yet assigned | — |
Medicinal ingredients
- APROTININ 10,000 UNIT per ML